Eli Lilly slips as obesity scripts said to trail those for Novo’s Wegovy

Eli Lilly (LLY) stock slips as IQVIA data show that the company's obesity drugs Zepbound and Foundayo lag Novo’s (NVO) Wegovy ...

Alphabet Advances In AI, Positioned To Gain Leadership (Earnings Preview)

Alphabet stock gets a "Strong Buy" rating and a $480 target as AI/cloud lead grows. Here's what investors need to know about ...